Apr 13 Watch 5:35 How abortion providers are navigating the swiftly-changing legal landscape By Geoff Bennett, Karina Cuevas The White House will ask the Supreme Court to intervene in the legal battle surrounding the abortion medication mifepristone. A federal appeals court ruled in favor of continuing access to the drug, but also limited its distribution through the mail… Continue watching
Apr 08 Watch 3:03 News Wrap: Justice Department probes potential leak of Pentagon documents In our news wrap Saturday, access to the abortion drug mifepristone is up in the air after dueling rulings from two federal judges, the DOJ launched an investigation into a potential leak of Pentagon documents detailing aid to Ukraine, China… Continue watching
Apr 07 FDA approval of abortion pill mifepristone in limbo after 2 federal judges order conflicting rulings By Paul J. Weber, Matthew Perrone, Associated Press A federal judge in Texas has thrown into jeopardy the most common method of abortion in the U.S., ordering regulators to temporarily halt their approval of the drug mifepristone for abortion. Continue reading
Mar 29 Watch 4:58 News Wrap: IAEA head says situation at Ukraine nuclear plant has worsened In our news wrap Wednesday, the head of the UN nuclear agency says the situation at the Zaporizhzhia nuclear plant in Ukraine has worsened since September, the U.S. Senate moved to reclaim war-making powers for Congress, Pope Francis has been… Continue watching
Mar 29 Narcan just got over-the-counter approval. Here’s what you need to know By Geoff Mulvihill, Associated Press The U.S. Food and Drug Administration on Wednesday approved selling naloxone without a prescription, setting the overdose-reversing drug on course to become the first opioid treatment drug to be sold over the counter. Continue reading
Mar 10 Cancer can go undetected in dense breasts. A new FDA rule will require providers to inform patients of that risk By Candice Norwood, The 19th The FDA on Thursday announced new regulations requiring mammogram providers to inform patients about the density of their breasts, a factor that increases the risk of breast cancer and can require additional screenings in order to properly detect the disease. Continue reading
Mar 07 FDA to recall 2 more eyedrop brands due to contamination risks By Associated Press U.S. health officials are alerting consumers about two more recalls of eyedrops due to contamination risks that could lead to vision problems and serious injury. Continue reading
Mar 03 Walgreens won’t sell an abortion pill in 20 states after threats of legal action. Here’s what that means By Tom Murphy, Associated Press Walgreens says it will not start selling an abortion pill in 20 states that had warned of legal consequences if it did that. Continue reading
Mar 02 Watch 5:20 New FDA guidelines on milk spark disagreements between farmers and plant-based companies By Stephanie Sy, Lena I. Jackson It’s almost official. Soy, almond and other plant-based drinks that call themselves milk can keep using that name, at least according to new draft guidelines released by the FDA last week. Stephanie Sy explores the debate. Continue watching
Mar 01 FDA panel narrowly backs Pfizer RSV vaccine for older adults By Matthew Perrone, Associated Press Federal health advisers have narrowly backed an experimental vaccine from Pfizer that could become the first shot to protect older adults against the respiratory illness known as RSV. Continue reading